CYB5R4
Summary: NCB5OR is a flavohemoprotein that contains functional domains found in both cytochrome b5 (CYB5A; MIM 613218) and CYB5 reductase (CYB5R3; MIM 613213) (Zhu et al., 1999 [PubMed 10611283]).[supplied by OMIM, Jan 2010].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
cytochrome b5 reductase 4 | MIM:608343 | Ensembl:ENSG00000065615 | HGNC:HGNC:20147 | PA134904907 | 6q14.2 |
Gene Categories:
DRUGGABLE GENOMEGO terms in CYB5R4
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IDA | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H |
MF | TAS | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H |
MF | IDA | GO:0016174 | NAD(P)H oxidase activity |
MF | IDA | GO:0016174 | NAD(P)H oxidase activity |
MF | IBA | GO:0016491 | oxidoreductase activity |
MF | IDA | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor |
MF | IEA | GO:0020037 | heme binding |
MF | IEA | GO:0046872 | metal ion binding |
MF | IBA | GO:0071949 | FAD binding |
CC | IBA | GO:0005783 | endoplasmic reticulum |
CC | IDA | GO:0005783 | endoplasmic reticulum |
CC | TAS | GO:0005789 | endoplasmic reticulum membrane |
CC | IDA | GO:0048471 | perinuclear region of cytoplasm |
BP | NAS | GO:0003032 | detection of oxygen |
BP | IBA | GO:0006091 | generation of precursor metabolites and energy |
BP | IDA | GO:0006091 | generation of precursor metabolites and energy |
BP | IBA | GO:0006801 | superoxide metabolic process |
BP | IDA | GO:0006801 | superoxide metabolic process |
BP | TAS | GO:0015701 | bicarbonate transport |
BP | ISS | GO:0030073 | insulin secretion |
BP | ISS | GO:0042593 | glucose homeostasis |
BP | ISS | GO:0046677 | response to antibiotic |
BP | ISS | GO:0048468 | cell development |
BP | IDA | GO:0055114 | oxidation-reduction process |
Gene expression in normal tissue: CYB5R4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CYB5R4
Database | Pathway ID | Pathway Des. |
---|---|---|
kegg | hsa00520 | Amino sugar and nucleotide sugar metabolism - Homo sapiens (human) |
wikipathways | WP43 | Oxidation by Cytochrome P450 |
reactome | R-HSA-1237044 | Erythrocytes take up carbon dioxide and release oxygen |
reactome | R-HSA-1480926 | O2/CO2 exchange in erythrocytes |
reactome | R-HSA-382551 | Transport of small molecules |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD505 | Pevonedistat | 2 |
iGMDRD552 | AZD-1775 | 3 |
iGMDRD263 | AACOCF3 | 3 |
iGMDRD147 | Prima-1 | 1 |
iGMDRD366 | PI-103 | 1 |
iGMDRD882 | CIL41 | 1 |
iGMDRD481 | Dactolisib | 1 |
iGMDRD267 | Oligomycin A | 1 |
iGMDRD289 | Parthenolide | 3 |
iGMDRD105 | Triptolide | 5 |
iGMDRD5 | Tyrphostin AG 1478 | 3 |
iGMDRD202 | Curcumin | 3 |
iGMDRD154 | NSC23766 | 3 |
iGMDRD945 | ML214 | 2 |
iGMDRD901 | ELCPK | 1 |
iGMDRD698 | Neratinib | 6 |
iGMDRD405 | PIK-75 | 3 |
iGMDRD424 | Tamatinib | 3 |
iGMDRD512 | nutlin 3 | 1 |
iGMDRD84 | Lovastatin acid | 3 |
iGMDRD486 | Tosedostat | 8 |
iGMDRD369 | TGX-115 | 3 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD577 | BIX01294 | 6 |
iGMDRD888 | Compound 44 | 2 |
iGMDRD780 | PP-30 | 1 |
iGMDRD398 | Sepantronium | 3 |
iGMDRD562 | Navitoclax | 2 |
iGMDRD188 | Piperlongumine | 3 |
iGMDRD887 | Compound 23 citrate | 5 |
iGMDRD399 | Selumetinib | 4 |
iGMDRD318 | PAC-1 | 10 |
iGMDRD870 | BRD63610 | 2 |
iGMDRD207 | Capsaicin | 1 |
iGMDRD782 | DC-45-A2 | 2 |
iGMDRD802 | 4-methylfasudil | 4 |
iGMDRD466 | Chaetocin | 4 |
iGMDRD394 | BX-795 | 2 |
iGMDRD280 | CYTOCHALASIN B | 8 |
iGMDRD316 | N9-Isopropyl-olomoucine | 3 |
iGMDRD152 | 179324-69-7 | 2 |
iGMDRD61 | Kinetin riboside | 3 |
iGMDRD781 | Sirolimus | 3 |
iGMDRD427 | ABT737 | 2 |
iGMDRD144 | NSC95397 | 6 |
iGMDRD387 | CHIR-99021 | 2 |
iGMDRD772 | BRD4770 | 6 |
iGMDRD126 | Tipifarnib | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CYB5R4